|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Article |
1 Istituto Superiore Sanità, Rome, Italy
2 Stanford University School of Medicine, Stanford, California
3 University of California at Merced, Merced, California
4 University of Florence, Florence, Italy
* To whom correspondence should be addressed. E-mail: migliar{at}iss.it.
| Abstract |
|---|
Two murine bipotent erythroid/megakaryocytic cells, the progenitor (MEP) and precursor(PEM) cells, have been recently identified on the basis of the phenotypes of linnegc-kitposSca-1neg CD16/CD32lowCD34low and TER119pos4A5pos or 2D5pos, respectively. However, the functional relationship between these two subpopulations and their placement in the hemopoietic hierarchy is incompletely understood. We compared the biological properties of these subpopulations in marrow and spleen of mice with and without acute or chronic erythroid stress. MEP, but not PEM, express c-kit, respond to SCF in vitro and form spleen colonies in vivo. PEM comprise up to 50-70% of the cells in BFU-E-derived colonies but are not present amongst the progeny of purified MEP cultured under erythroid and megakaryocytic permissive conditions. PEM increase 10 to 20 fold under acute and chronic stress, whereas MEP increases (21 to 84%) are only observed in acutely stressed animals. These data suggest that MEP and PEM represent distinct cell populations that may exist in an upstream-downstream differentiation relationship under conditions of stress. While the dynamics of both populations are altered by stress induction, the differential response to acute and chronic stress suggests different regulatory mechanisms. A model describing the relationship between MEP, PEM and CMP is presented.
Key Words. erythroid progenitors, megakaryocytic progenitors, erythroid stress, GATA-1, phenyl-hydrazine
This article has been cited by other articles:
![]() |
F. Bouilloux, G. Juban, N. Cohet, D. Buet, B. Guyot, W. Vainchenker, F. Louache, and F. Morle EKLF restricts megakaryocytic differentiation at the benefit of erythrocytic differentiation Blood, August 1, 2008; 112(3): 576 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sawado, J. Halow, H. Im, T. Ragoczy, E. H. Bresnick, M. A. Bender, and M. Groudine H3 K79 dimethylation marks developmental activation of the {beta}-globin gene but is reduced upon LCR-mediated high-level transcription Blood, July 15, 2008; 112(2): 406 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Martelli, B. Ghinassi, R. Lorenzini, A. M. Vannucchi, R. A. Rana, M. Nishikawa, S. Partamian, G. Migliaccio, and A. R. Migliaccio Thrombopoietin Inhibits Murine Mast Cell Differentiation Stem Cells, April 1, 2008; 26(4): 912 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ghinassi, M. Sanchez, F. Martelli, G. Amabile, A. M. Vannucchi, G. Migliaccio, S. H. Orkin, and A. R. Migliaccio The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor Blood, February 15, 2007; 109(4): 1460 - 1471. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
